Pharmaceutical companies in the United States by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 27 pharmaceutical companies in the United States ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 20 Nov 2026, 02:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 27
- First
- Royalty Pharma65.6%
- Median
- 5.88%
- Combined market value
- NOK 36.51T
- Countries
- 1
- Not ranked
- 17no operating margin on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | NOK 380.5B | NOK 661.77 | 1.38% down | 79% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | NOK 47.6B | NOK 569.96 | 3.16% down | 21% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | NOK 232.7B | NOK 5,463.64 | 3.16% down | 22% up | ||
| 4 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | NOK 1.29T | NOK 5,088.00 | 2.94% down | 27% up | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | NOK 933.4B | NOK 9,023.07 | 2.35% down | 28% up | ||
| 6 | AbbVieABBV · Health Care | 24.6% | NOK 4.9T | NOK 2,770.81 | 0.86% down | 25% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | 20.0% | NOK 95.8B | NOK 634.02 | 1.88% down | 117% up | ||
| 8 | Abbott LaboratoriesABT · Health Care | 18.2% | NOK 1.76T | NOK 1,015.04 | 0.58% down | 16% down | ||
| 9 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | NOK 56.1B | NOK 2,804.04 | 3.94% down | 50% up | ||
| 10 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | NOK 193.5B | NOK 1,444.53 | 1.06% down | 66% down | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | NOK 72.8B | NOK 209.03 | 2.24% down | 90% up | ||
| 12 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | NOK 116.3B | NOK 600.21 | 0.02% down | 17% up | ||
| 13 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | NOK 60.3B | NOK 426.56 | 1.25% up | 13% up | ||
| 14 | Corcept TherapeuticsCORT · Health Care | 5.88% | NOK 69.5B | NOK 635.00 | 4.15% down | 10% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | NOK 60.9B | NOK 933.34 | 3.27% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | -12.8% | NOK 45.3B | NOK 472.00 | 3.86% down | 45% up | ||
| 17 | Legend BiotechLEGN · Health Care | -13.3% | NOK 30.5B | NOK 157.33 | 0.92% down | 41% down | ||
| 18 | ViatrisVTRS · Health Care | -18.6% | NOK 222.7B | NOK 194.27 | 1.97% down | 99% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -26.1% | NOK 69.7B | NOK 1,325.89 | 1.25% up | 6% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | NOK 90.1B | NOK 3,877.03 | 0.34% down | 27% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | NOK 44.3B | NOK 266.00 | 0.62% down | 63% down | ||
| 22 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | NOK 79.1B | NOK 1,141.39 | 1.88% down | 18% up | ||
| 23 | BridgeBio PharmaBBIO · Health Care | -104% | NOK 148.8B | NOK 763.99 | 0.22% up | 21% up | ||
| 24 | InsmedINSM · Health Care | -206% | NOK 309.7B | NOK 1,411.69 | 20.58% up | 40% down | ||
| 25 | Protagonist TherapeuticsPTGX · Health Care | -344% | NOK 79.1B | NOK 1,211.95 | 2.47% down | 51% up | ||
| 26 | CytokineticsCYTK · Health Care | -695% | NOK 70.1B | NOK 502.88 | 0.27% up | 19% down | ||
| 27 | Dianthus TherapeuticsDNTH · Health Care | -8739% | NOK 46.7B | NOK 828.98 | 1.01% up | 108% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7722 NOK). 17 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 27 pharmaceutical companies in the United States ranked by operating margin as of 20 Nov 2026, 02:43 UTC.
How many pharmaceutical companies in the United States are in this ranking?
27 are ranked by operating margin. 17 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 27 pharmaceutical companies in the United States ranked by operating margin have a combined market value of NOK 36.51T as of 20 Nov 2026, 02:43 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by operating margin”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.